Loncastuximab tesirine: Risk for dose variance.
Am J Health Syst Pharm
; 81(11): e271-e273, 2024 May 24.
Article
in En
| MEDLINE
| ID: mdl-38298157
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Dose-Response Relationship, Drug
Type of study:
Etiology_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Am J Health Syst Pharm
Journal subject:
FARMACIA
/
HOSPITAIS
Year:
2024
Document type:
Article
Affiliation country:
United States
Country of publication:
United kingdom